BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 19267921)

  • 21. [E-selectin and its ligand-sLeX in the metastasis of hepatocellular carcinoma].
    Zhang B; Chen H; Yao X; Cong W; Wu M
    Zhonghua Wai Ke Za Zhi; 2000 Jul; 38(7):534-6. PubMed ID: 11832103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IL-2, -4, and -15 differentially regulate O-glycan branching and P-selectin ligand formation in activated CD8 T cells.
    Carlow DA; Corbel SY; Williams MJ; Ziltener HJ
    J Immunol; 2001 Dec; 167(12):6841-8. PubMed ID: 11739501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of 16 human colon carcinoma cell lines for their expression of sialyl LeX antigens and their E-selectin-dependent adhesion.
    Nemoto Y; Izumi Y; Tezuka K; Tamatani T; Irimura T
    Clin Exp Metastasis; 1998 Aug; 16(6):569-76. PubMed ID: 9872604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. UDP-GlcNAc:Galbeta1-->3GalNAc (GlcNAc to GalNAc) beta1-->6N-acetylglucosaminyltransferase holds a key role on the control of CD15s expression in human pre-B lymphoid cell lines.
    Nakamura M; Furukawa Y; Sasaki R; Masuyama J; Kikuchi J; Iwase S; Kudo T; Narimatsu H; Asakura S; Fujiwara S; Inokuchi J
    Glycobiology; 1999 Jan; 9(1):1-12. PubMed ID: 9884401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alpha 1-acid glycoprotein (AGP): a possible carrier of sialyl lewis X (slewis X) antigen in colorectal carcinoma.
    Croce MV; Sálice VC; Lacunza E; Segal-Eiras A
    Histol Histopathol; 2005 Jan; 20(1):91-7. PubMed ID: 15578427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two E-selectin ligands, BST-2 and LGALS3BP, predict metastasis and poor survival of ER-negative breast cancer.
    Woodman N; Pinder SE; Tajadura V; Le Bourhis X; Gillett C; Delannoy P; Burchell JM; Julien S
    Int J Oncol; 2016 Jul; 49(1):265-75. PubMed ID: 27176937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
    J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An sLex-deficient variant of HL60 cells exhibits high levels of adhesion to vascular selectins: further evidence that HECA-452 and CSLEX1 monoclonal antibody epitopes are not essential for high avidity binding to vascular selectins.
    Wagers AJ; Stoolman LM; Craig R; Knibbs RN; Kansas GS
    J Immunol; 1998 May; 160(10):5122-9. PubMed ID: 9590264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical significance of BMP7 in human colorectal cancer.
    Motoyama K; Tanaka F; Kosaka Y; Mimori K; Uetake H; Inoue H; Sugihara K; Mori M
    Ann Surg Oncol; 2008 May; 15(5):1530-7. PubMed ID: 18259822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. E-selectin and its ligand-sLeX in the metastasis of hepatocellular carcinoma.
    Zhang BH; Chen H; Yao XP; Cong WM; Wu MC
    Hepatobiliary Pancreat Dis Int; 2002 Feb; 1(1):80-2. PubMed ID: 14607629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High expression of sLex associated with poor survival in Argentinian colorectal cancer patients.
    Zwenger A; Rabassa M; Demichelis S; Grossman G; Segal-Eiras A; Croce MV
    Int J Biol Markers; 2014 Mar; 29(1):e30-9. PubMed ID: 24425323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reg IV, a new member of the regenerating gene family, is overexpressed in colorectal carcinomas.
    Violette S; Festor E; Pandrea-Vasile I; Mitchell V; Adida C; Dussaulx E; Lacorte JM; Chambaz J; Lacasa M; Lesuffleur T
    Int J Cancer; 2003 Jan; 103(2):185-93. PubMed ID: 12455032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mucins secreted by cell lines derived from colorectal mucinous carcinoma and adenocarcinoma.
    Cho M; Dahiya R; Choi SR; Siddiki B; Yeh MM; Sleisenger MH; Kim YS
    Eur J Cancer; 1997 May; 33(6):931-41. PubMed ID: 9291818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced expression of the metastasis suppressor gene KAI1 in advanced colon cancer and its metastases.
    Maurer CA; Graber HU; Friess H; Beyermann B; Willi D; Netzer P; Zimmermann A; Büchler MW
    Surgery; 1999 Nov; 126(5):869-80. PubMed ID: 10568187
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased expression of S100A4, a metastasis-associated gene, in human colorectal adenocarcinomas.
    Takenaga K; Nakanishi H; Wada K; Suzuki M; Matsuzaki O; Matsuura A; Endo H
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2309-16. PubMed ID: 9815629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated protein expression of cyclin D1 and Fra-1 but decreased expression of c-Myc in human colorectal adenocarcinomas overexpressing beta-catenin.
    Wang HL; Wang J; Xiao SY; Haydon R; Stoiber D; He TC; Bissonnette M; Hart J
    Int J Cancer; 2002 Oct; 101(4):301-10. PubMed ID: 12209953
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in CXCL12/CXCR4-chemokine expression during onset of colorectal malignancies.
    Oliveira Frick V; Rubie C; Ghadjar P; Faust SK; Wagner M; Gräber S; Schilling MK
    Tumour Biol; 2011 Feb; 32(1):189-96. PubMed ID: 20865359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression and significance of CD44s, CD44v6, and nm23 mRNA in human cancer.
    Liu YJ; Yan PS; Li J; Jia JF
    World J Gastroenterol; 2005 Nov; 11(42):6601-6. PubMed ID: 16425351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. L-Selectin ligands that are O-glycoprotease resistant and distinct from MECA-79 antigen are sufficient for tethering and rolling of lymphocytes on human high endothelial venules.
    Clark RA; Fuhlbrigge RC; Springer TA
    J Cell Biol; 1998 Feb; 140(3):721-31. PubMed ID: 9456330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single glycosyltransferase, core 2 beta1-->6-N-acetylglucosaminyltransferase, regulates cell surface sialyl-Lex expression level in human pre-B lymphocytic leukemia cell line KM3 treated with phorbolester.
    Nakamura M; Kudo T; Narimatsu H; Furukawa Y; Kikuchi J; Asakura S; Yang W; Iwase S; Hatake K; Miura Y
    J Biol Chem; 1998 Oct; 273(41):26779-89. PubMed ID: 9756922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.